ATRC (AtriCure Corp) יחס שווי שוק לשווי בספרים
AtriCure, Inc. (ATRC) financial flows rely on the popularization of minimally invasive therapies, while the legal protection of intellectual property and medical training courses stabilize demand. AtriCure, Inc. (ATRC) maintains leadership in atrial fibrillation treatment through unique patents that create significant barriers to entry for competitors. This price chart on GURU.Markets, where the indicator stands at 5.96, serves as confirmation of the market valuation and supports an expansion strategy driven by physician education and the proven efficacy of its tools.
%20-%20%D7%99%D7%97%D7%A1%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_ATRC_-_AtriCure-Inc._-_Market-Cap-to-Net-Assets-Ratio "ATRC יחס שווי שוק לערך בספרים AtriCure (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
ATRC (AtriCure Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים
This indicator compares the market value of AtriCure, Inc. (ATRC) to its net assets, determining the premium for capital efficiency. By analyzing the current price-to-book ratio, investors assess the extent to which the market overvalues assets due to the company's leadership in the surgical atrial fibrillation treatment segment and its unique physician education strategy.